Ensysce Biosciences, Inc. (ENSC) Stock Forecast & Price Target
Price as of Nov 17, 2026 close · Analyst estimates retrieved Nov 17, 2026 · Source: Financial Modeling Prep (analyst estimates) (methodology)
Revenue and earnings estimates published by analysts covering Ensysce Biosciences, Inc. (ENSC), and the range of their price targets. Everything on this page is a forecast made by other people — DeltaScreener does not produce estimates or targets of its own.
For Ensysce Biosciences, Inc., analysts forecast revenue rising from $3.70M in 2025 to $14.50M in 2030; the average estimate for 2030 earnings per share is −$0.09; with published estimates ranging from −$0.10 to −$0.08; 2 analysts contribute to these figures. These are forecasts published by analysts, not results.
Revenue forecast (USD)
The spread between low and high is how far analysts disagree, which is usually a better guide than the average alone.
Earnings per share forecast
Ensysce Biosciences, Inc. (ENSC) forecast — frequently asked questions
What are analysts forecasting for Ensysce Biosciences, Inc.'s earnings?
The average analyst estimate for Ensysce Biosciences, Inc. (ENSC) earnings per share in 2030 is -0.09, with individual estimates between -0.10 and -0.08.
How much revenue is Ensysce Biosciences, Inc. expected to make?
Analysts forecast Ensysce Biosciences, Inc. (ENSC) revenue of $14.50M in 2030, based on 1 published estimates.
How many analysts cover ENSC?
2 analysts contribute estimates for Ensysce Biosciences, Inc. (ENSC). Thin coverage makes an average less reliable.
Analyst forecasts for other Biotechnology stocks
Popular Stocks
Related stock screens
Data for information only, not investment advice. Figures may be delayed or inaccurate; verify against company filings. See our disclaimer.